
About Cencora
Cencora (NYSE:COR) operates in the healthcare sector, focusing on providing a broad range of services aimed at enhancing patient care while effectively managing costs. With its diversified approach, Cencora is involved in health insurance plans, pharmacy benefit management, and specialty healthcare services, aiming to deliver comprehensive solutions that cater to the evolving needs of both individuals and healthcare providers. The company’s operations span across various regions, seeking to expand its footprint through strategic projects and partnerships. A key objective for Cencora is to leverage technology and innovation to improve healthcare accessibility and outcomes, ensuring a patient-centric approach in all its endeavors. Its commitment to sustainability, community support, and ethical practices underscores its mission to contribute positively to the health sector's future.
Snapshot
Operations
Products and/or services of Cencora
- Advanced distribution services for pharmaceuticals ensuring timely delivery to healthcare providers.
- Specialty pharmacy services offering personalized medication management for complex treatments.
- Innovative technology solutions for pharmacy management and data analytics.
- Clinical services program aimed at improving patient outcomes and adherence.
- Direct-to-patient services including home delivery and digital health tools.
- Global sourcing and procurement strategies for medication supply chain efficiency.
Cencora executive team
- Dr. Robert P. Mauch Ph.D., PharmDPresident, CEO & Director
- Mr. James F. Cleary Jr.Executive VP & CFO
- Ms. Elizabeth S. Campbell J.D.Executive VP & Chief Legal Officer
- Ms. Silvana BattagliaExecutive VP & Chief Human Resources Officer
- Mr. Lazarus KrikorianSenior VP, Chief Accounting Officer & Corporate Controller
- Mr. Pawan Singh VermaExecutive VP and Chief Data & Information Officer
- Mr. Bennett S. MurphySenior VP Of Investor Relations & Enterprise Productivity and Treasury
- Ms. Jennifer E. DubasSenior VP & Chief Compliance Officer
- Mr. Richard TremonteEVP and President of U.S. Pharmaceuticals & Animal Health
- Mr. Juan GuerraEVP & President of International Business Group